Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based

Muideen Tunbosun Olaiya1, Hung-Yi Chiou, Jiann-Shing Jeng

  • 1School of Public Health, Taipei Medical University, Taipei, Taiwan.

Plos One
|October 8, 2013
PubMed

Insights

Gallstone disease (GD) significantly increases the risk of developing cardiovascular disease (CVD). This risk is particularly elevated in younger individuals, suggesting GD prevention may reduce CVD incidence.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstone disease (GD) is a common condition.
  • Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
  • The potential link between GD and CVD risk requires further investigation.

Purpose of the Study:

  • To determine if gallstone disease (GD) is associated with an increased risk of developing cardiovascular disease (CVD).
  • To analyze the association in a large population-based cohort over a six-year follow-up period.

Main Methods:

  • Utilized the Taiwan National Health Insurance Research Database (2004-2005) to identify 6,981 patients with GD.
  • Matched 27,924 patients without GD for age and gender.
  • Employed Cox proportional hazards regression to assess CVD risk, adjusting for covariates.

Main Results:

  • Patients with GD exhibited a 32% higher risk of developing CVD (HR, 1.32; 95% CI, 1.22-1.43).
  • Elevated risks were observed for stroke, coronary heart disease, and heart failure.
  • Younger GD patients (18-40 years) showed a significantly higher CVD risk (HR, 1.42; 95% CI, 1.09-1.84).

Conclusions:

  • Gallstone disease (GD) is linked to an increased risk of cardiovascular disease (CVD).
  • The association between GD and CVD is particularly pronounced in younger populations.
  • Preventive strategies for GD may contribute to reducing the overall burden of CVD, especially in younger individuals.
Abstract

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
33
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Gallbladder01:17

Gallbladder

The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
3.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747